GIN-U836, CIC-CHU de Grenoble
The CHU platform has expertise in cell therapy and neuroscience clinical trials. It is associated with:
• A neurovascular unit carrying a clinical trial using MSC for the treatment of strokes.
• A center for clinical investigation carrying clinical trials in biotherapy (diabetes, ischemia of the lower limbs, stroke) and in immunotherapy (melanoma).
Neuroscience models, preclinical and clinical MRI, clinical trials, cell therapy